|
|
Volumn 148, Issue 5, 2004, Pages 834-841
|
|
Effect of age on the use of evidence-based therapies for acute myocardial infarction.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
AGE;
AGED;
ARTICLE;
COHORT ANALYSIS;
FEMALE;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
MALE;
MIDDLE AGED;
PRACTICE GUIDELINE;
RETROSPECTIVE STUDY;
UTILIZATION REVIEW;
ADRENERGIC BETA-ANTAGONISTS;
AGE FACTORS;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ASPIRIN;
COHORT STUDIES;
FEMALE;
GUIDELINE ADHERENCE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PRACTICE GUIDELINES;
RETROSPECTIVE STUDIES;
THROMBOLYTIC THERAPY;
MLCS;
MLOWN;
|
|
EID: 16644386970
PISSN: None
EISSN: 10976744
Source Type: Journal
DOI: 10.1016/j.ahj.2003.11.028 Document Type: Article |
|
Times cited : (54)
|
|
References (0)
|
